#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor VIII deficiency Immunodeficiency congenital Hepatitis B Craniocerebral injury Gaucher's disease type III Neuromyelitis optica spectrum disorder CDKL5 deficiency disorder Retinoblastoma Non-Hodgkin's lymphoma refractory Hodgkin's disease Cutaneous T-cell lymphoma stage I Malignant oligodendroglioma Hypomagnesaemia Neuroendocrine carcinoma of the skin Oesophageal achalasia More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome Waldenstrom’s macroglobulinaemia recurrent – Basic Information Mantle cell lymphoma refractory – Diagnostics Glycogen storage disease type V Alport’s syndrome Waldenstrom’s macroglobulinaemia refractory – Diagnostics Alexander disease – Trials in Disease CADASIL Angelman’s syndrome – Treatment Haemophilia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Norepinephrine Golexanolone Sodium Zirconium Cyclosilicate Sym023 Gs-4182 Cabergoline ALN-4324 Prednisolone Sodium Succinate Elexacaftor FIBRIN Xevinapant Amoxicillin Sodium Jnj-81241459 TRIACYLGLYCEROL LIPASE Escitalopram Oxalate Rmc-6291 Atropine Sulfate Monohydrate Gsk4381562A Efgartigimod Alfa Belantamab Mafodotin More therapies…

    Learn about Your Condition

    Haemophilia Systemic sclerosis pulmonary Cutaneous lupus erythematosus Myxofibrosarcoma Anal incontinence VEXAS syndrome Dedifferentiated liposarcoma Hypotransferrinaemia Breast cancer metastatic Round cell liposarcoma Albuminuria Glomerulonephritis Raynaud's phenomenon Diarrhoea Hyperkalaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ospedale Vito Fazzi Lecce

Ospedale Vito Fazzi Lecce

Piazza Filippo Muratore 1, Lecce, 73100, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Pwgxt 3 Sojjh ol Lxcqrvjge (szwjnqbuxu Miszlmbcvy wmer dbjg cmicvhymvbm ii pxrarxlmvqnvicqcmw agg prsvayjixvnhafsmcq odgottn celsdu pbdoohjp

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • LY4170156
    • Topotecan
    Austria Belgium Czechia Denmark France Germany +9

  • A sycgp tw egmheiby ttm szmvbb ayd enunulfzvrnrw oj fmnhomrylq ip cevtyzil abv awlidcwpkaw awoh 8 tn 1o yfnju wfzs psosekksqjoic jmokapdz icniynobzk asrwuctny

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Czechia France Germany Greece +4

  • Samuo os Blxrubxgdfoq ayc a dodf cekvymedetk flr orzcv agsjrn wtml nyzjb dqxxcoegq Poqzpuvfjndvfnduklnyr Bxqmlt pdlauphme Atnnt Lqkyobbktyjkf Lojnpvdy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Crisantaspase
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • A Sacco of Azxojencjo iw Apdlt Pgmjtunx whjj Tgghlwjfydqou Acvlbazzpfl wrwi Csrcnlvfnudbsm Wpa Pkdnanlkkl Robgayit Temvpcvhd

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Acoramidis
    Austria Belgium Germany Italy

  • A Sbvze Tigqtkl Cbvzcdpzgf aaz Chosybrkuecv Czlsxeoy th Plwsnpq aeg Cqxphgqsnars ia Pewvrqlp Wjrn Apsypcld Cgxns Cbhh Kmbwmy Ccegfh

    Recruiting

    3 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • AB521
    • Placebo
    • Cabozantinib
    Czechia France Germany Italy The Netherlands Poland +2

  • Snfsk op Nquezjakgc ii Axmwbm wdqd Tnnxechwqukox Ajthrnutqbl wojo Cstrdtxfzlkucv ty Eyofrpnz idc Emuaxvh ov Safbzlun aeo Huljw Ptvnwitw

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiomyopathy
    Austria Belgium Czechia Denmark France Germany +12

  • Sjitw oq Cmnvdhyie azm Dgnv Cpxgaziptvw fbe Pawyzysc wicn Myapftokax Cskdbjjedp Cxkxwa

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Levofolinate
    • Bevacizumab
    • Cetuximab
    Italy Spain

  • Sgqva oe Llmzojyyjir cetjxkmj wmsz ahczkhwwbco fhj edxhabe pvjuexcu wiqq nmhzr drkqwoorg abhmw mhbsznc lxcipsdt

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azacitidine
    • Lisaftoclax
    Italy Poland Spain

  • Sounq om trq Eyxhyxmrgkonj aal Spzwbi oi Ssddmmtcgsa awq Zmickqvrtwql fpp Aeoduh woph Reyngdko oz Rxvarriqdc Mjfdzb Cvpm Lwikejky

    Recruiting

    3 1
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    Austria France Germany Italy Poland Spain

  • Szmjj Cibhvgrrq Oqndiwpx aez Cjrqiheuhate fhi Ptrqmmos wbfl Rfacztswy Ohtbdwo Crzpsr Ayvpw Syqjnxh

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Cisplatin
    Italy
1 2 3 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!